Skip to main content

Table 1 Patient characteristics

From: Hydroxyapatite-coated cementless total hip arthroplasty for patients undergoing dialysis: a study of 30 hips with a minimum follow-up period of 5 years

Hips/patients, n

30/24

Sex, male and female

4 (13.3) and 26 (86.7)

Age at primary THA, years

55.9 ± 9.2 (43–74)

Height, cm

151.0 ± 8.9 (136.8–164.8)

Weight, kg

43.3 ± 7.3 (35.1–59.6)

Body mass index, kg/m2

19.5 ± 3.0 (15.7–25.8)

Follow-up period after primary THA, months

111.8 ± 41.0 (60–216)

Causes of renal failure

 Chronic glomerulonephritis

14 (46.7)

 Diabetes mellitus

3 (10.0)

 Systemic lupus erythematosus

2 (6.7)

 Polycystic kidney disease

2 (6.7)

 Hypertension

2 (6.7)

 Preeclampsia

2 (6.7)

 Allergic purpura

2 (6.7)

 ANCA-related glomerulonephritis

1 (3.3)

 Unknown

2 (6.7)

Duration of dialysis before primary THA, months

144.1 ± 114.4 (2–408)

Preoperative diagnosis for primary THA

 Osteoarthritis

21 (70.0)

 Osteonecrosis

8 (26.7)

 Fracture

1 (3.3)

  1. Data are presented as n (%) or mean ± standard deviation (range). THA total hip arthroplasty, ANCA antineutrophil cytoplasmic antibodies